• First Patient Dosed in Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma
  • Gamida Recruiting Myeloma Patients for Phase 1 Trial of Its Killer Cells-based Therapy
  • Potential Myeloma Therapy Shows Positive Interim Phase 2 Trial Results, According to Report
  • Multiple Myeloma Patients Remain On Treatment Far Less than in Clinical Trials, Study Finds
  • Empliciti Improves Response to Combo Treatment in Newly Diagnosed Myeloma Patients, Study Finds
  • FDA Extends Xgeva Approval to Include Myeloma Patients with Bone Lesions
  • Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice
  • Janssen and Legend Biotech Joining Forces to Advance Myeloma CAR T-cell Therapy
  • BioLineRx Readies Phase 3 Myeloma Trial to Mobilize Stem Cells for Transplant
  • Biomarker Found That Detects Myeloma Patients Who Will Benefit from Stem Cell Transplant
  • CellProtect Receives EU Orphan Drug Status for Treatment of Multiple Myeloma
  • Adaptimmune Immunotherapy Increases Time It Takes for Myeloma to Progress, Trial Shows